Repeat Emergency Department Visits Among Patients With Asthma and COPD
NCT02499887 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2019-06-04
Summary
The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency department to home. The investigators hypothesize that patients treated with inhaled corticosteroids in addition to oral corticosteroids and albuterol will have lower rates of 30-day return visits to the emergency department than those patients treated with oral corticosteroids and albuterol only.
Conditions
Interventions
- DRUG
-
beclamethasone dipropionate
Inhaler
- DRUG
-
albuterol
Inhaler
- DRUG
-
Oral corticosteroid
Sponsors & Collaborators
-
State University of New York at Buffalo
lead OTHER
Principal Investigators
-
Heather A Lindstrom, PhD · University at Buffalo, Department of Emergency Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
NCT00588406 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-response of Albuterol in Asthmatics
NCT00940927 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
NCT05292976 ·Status: WITHDRAWN ·Phase: PHASE3
-
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
NCT01332357 ·Status: COMPLETED
-
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
NCT01581177 ·Status: COMPLETED ·Phase: PHASE2
-
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
NCT07228052 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol
NCT00325767 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
NCT01881412 ·Status: TERMINATED ·Phase: NA
-
Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
NCT03371459 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
NCT00528723 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073827 ·Status: COMPLETED ·Phase: PHASE3
-
Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma
NCT03835871 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
NCT02969408 ·Status: COMPLETED ·Phase: PHASE3
-
Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department
NCT00388739 ·Status: WITHDRAWN ·Phase: NA
-
Steroids in Children Hospitalized With Asthma
NCT02780479 ·Status: TERMINATED ·Phase: PHASE4
-
Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
NCT01189396 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
NCT00667407 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
NCT01058863 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Reported Outcomes for Acute Asthma Care Treatment
NCT04349020 ·Status: RECRUITING
-
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Asthma Relapse After Discharge From Emergency
NCT00326053 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
NCT00073814 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol
NCT02424409 ·Status: COMPLETED ·Phase: NA